Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Composition of the cardiac IKs channel complex as a determinant of the KCNQ1 mutation disease phenotype

EF 2021-22

Résumé
In the heart, KCNQ1 (Q1) is a potassium pore which associates with the regulatory subunit KCNE1 to form the I ion channel complex. I is essential in maintaining cardiac rhythm as it is responsible for relaxing cardiac cells and terminating the hearts contraction, especially at rapid heart rates. Mutations in Q1 impair cardiac repolarization, and so may cause arrhythmias which are irregular heartbeat disorders that may pose serious consequences such as stroke and sudden cardiac death. Mutations decreasing Q1 function are associated with arrhythmias like long QT syndrome while those increasing Q1 function are linked to atrial fibrillation and short QT syndrome. In some cases, Q1 mutations can cause mixed observable characteristics (phenotypes), suggesting that the disease phenotype may be dictated by heterogeneity of the I channel composition. Although other KCNE subunits may participate in the I channel complex, their contribution to disease phenotypes is largely unknown. Thus, I hypothesize that Q1 mutation-related phenotypes depend on the nature of the associated regulatory subunits as well as their number within the I channel complex. To test my hypothesis, I will use modern molecular biology techniques to generate Q1 mutations, and state-of-the-art cellular biophysical methods such as the patch clamp technique to record ionic currents resulting from co-expression of Q1 mutants with various combinations of KCNE subunits. Findings will be translated to more physiologically relevant human cardiac muscle cells to recapitulate disease phenotypes in genetically modified human atrial and ventricular cells. Our experiments will contribute to the elucidation of gene-specific arrhythmia mechanisms and help define the most optimal treatment strategies.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466586
Name
Chan Magnus
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Composition of the cardiac IKs channel complex as a determinant of the KCNQ1 mutation disease phenotype
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arrhythmia; Atrial Fibrillation; Gene Expression; Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes; Ion Channels; Long Qt Syndrome; Microelectrode Array; Mutations; Patch Clamp; Potassium Currents
Abstract
In the heart, KCNQ1 (Q1) is a potassium pore which associates with the regulatory subunit KCNE1 to form the I ion channel complex. I is essential in maintaining cardiac rhythm as it is responsible for relaxing cardiac cells and terminating the hearts contraction, especially at rapid heart rates. Mutations in Q1 impair cardiac repolarization, and so may cause arrhythmias which are irregular heartbeat disorders that may pose serious consequences such as stroke and sudden cardiac death. Mutations decreasing Q1 function are associated with arrhythmias like long QT syndrome while those increasing Q1 function are linked to atrial fibrillation and short QT syndrome. In some cases, Q1 mutations can cause mixed observable characteristics (phenotypes), suggesting that the disease phenotype may be dictated by heterogeneity of the I channel composition. Although other KCNE subunits may participate in the I channel complex, their contribution to disease phenotypes is largely unknown. Thus, I hypothesize that Q1 mutation-related phenotypes depend on the nature of the associated regulatory subunits as well as their number within the I channel complex. To test my hypothesis, I will use modern molecular biology techniques to generate Q1 mutations, and state-of-the-art cellular biophysical methods such as the patch clamp technique to record ionic currents resulting from co-expression of Q1 mutants with various combinations of KCNE subunits. Findings will be translated to more physiologically relevant human cardiac muscle cells to recapitulate disease phenotypes in genetically modified human atrial and ventricular cells. Our experiments will contribute to the elucidation of gene-specific arrhythmia mechanisms and help define the most optimal treatment strategies.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chan, Magnus
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~